Cagrisema, a potential drug to be launched by Novo Nordisk in 2026, is estimated to have revenue of over ** billion U.S. dollars. Orforglipron a drug by Eli Lilly, will be launched in 2026, and the revenue is estimated to be around ** billion U.S. dollars in 2032.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Evaluate Vantage. (January 7, 2026). Major pharma and biotech drug launches in 2026, by revenue estimates for 2032 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved August 04, 2026, from /statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
Evaluate Vantage. "Major pharma and biotech drug launches in 2026, by revenue estimates for 2032 (in billion U.S. dollars)." Chart. January 7, 2026. ÌÇÐÄÆÆ½â°æ. Accessed August 04, 2026. /statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
Evaluate Vantage. (2026). Major pharma and biotech drug launches in 2026, by revenue estimates for 2032 (in billion U.S. dollars). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: August 04, 2026. /statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
Evaluate Vantage. "Major Pharma and Biotech Drug Launches in 2026, by Revenue Estimates for 2032 (in Billion U.S. Dollars)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 7 Jan 2026, /statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
Evaluate Vantage, Major pharma and biotech drug launches in 2026, by revenue estimates for 2032 (in billion U.S. dollars) ÌÇÐÄÆÆ½â°æ, /statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/ (last visited August 04, 2026)
Major pharma and biotech drug launches in 2026, by revenue estimates for 2032 (in billion U.S. dollars) [Graph], Evaluate Vantage, January 7, 2026. [Online]. Available: /statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/